This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Number of primary studies included
Results of 13 studies of TCC treatment were tabulated: 11 studies described more than 1 patient. Five studies using other methods of treatment were quoted in the text but were not included in the table of results. Outcomes for controls were provided by 5 studies, 1 of which also provided TCC data. A total of 22 studies was used in the review.
Methods of combining primary studies
Primary studies were not combined in a systematic way. The average of percentage recurrence rates was worked out as a simple arithmetic mean of the 5 studies to give recurrence rates, without reference to original data and without allowing for ranges or different numbers in studies. The method of combining studies to produce mean healing times and percentages healed was not explained. Complication rates were not combined.
Investigation of differences between primary studies
Differences between primary studies were not investigated. Theauthor comments that studies used different definitions of a healed ulcer which makes comparisons difficult. He did not say how, or if, he had made allowance for this.
Results of the review
The mean healing times are approximate since only a bar chart was given. Using TCC, healing time was 45 days: using dressing changes and moulded insoles it was 88 days; using local ostectomy and wound debridement it was 130 days; and using CT-102 it was 140 days (median for this last case). The percentage of ulcers healed was also presented as a chart. Using TCC 90% were healed, using dressing changes and moulded insoles 67% were healed, using local ostectomy and wound debridement 57% were healed, and using CT-102 60% were healed. Complication rates were not combined and were only given for TCC. They varied from 6 to 43 %. The only recurrence rate given was for TCC and was stated as 32%.
Measure of benefits used in the economic analysis
Mean healing time in days, percentage of ulcers healed, recurrence rate.
Direct costs
Costs were not discounted despite the fact that the period covered in the analysis was 2 years. The mean length of hospital stay was reported along with the number of cast changes. Average hospital stays for diabetes patients were based on a previous study. Hospital room costs were derived from the institution's data. This was a deliberately conservative estimate as costs of medications, diagnostic procedures and physicians services were not included. Costs were estimated for an 8 week outpatient duration of casting including 6 to 8 casts. It is not clear what cost boundary was represented, apart from that of the hospital. Costs were said to be current and the study was published in 1996. For the comparators, the only relevant information given was mean healing time in days which was based on reports from previously published studies.
Indirect Costs
It was stated that, as TCC allows patients to remain ambulatory, no loss of wages need occur. Apart from this, indirect costs were not considered.
